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Abstract
Background: In South Africa, stigma, discrimination, social visibility and fear of loss of confidentiality impede health facility-
based HIV testing. With 50% of adults having ever tested for HIV in their lifetime, private, alternative testing options are
urgently needed. Non-invasive, oral self-tests offer a potential for a confidential, unsupervised HIV self-testing option, but
global data are limited.
Methods: A pilot cross-sectional study was conducted from January to June 2012 in health care workers based at the
University of Cape Town, South Africa. An innovative, unsupervised, self-testing strategy was evaluated for feasibility;
defined as completion of self-testing process (i.e., self test conduct, interpretation and linkage). An oral point-of-care HIV
test, an Internet and paper-based self-test HIV applications, and mobile phones were synergized to create an unsupervised
strategy. Self-tests were additionally confirmed with rapid tests on site and laboratory tests. Of 270 health care workers (18
years and above, of unknown HIV status approached), 251 consented for participation.
Findings: Overall, about 91% participants rated a positive experience with the strategy. Of 251 participants, 126 evaluated
the Internet and 125 the paper-based application successfully; completion rate of 99.2%. All sero-positives were linked to
treatment (completion rate:100% (95% CI, 66.0–100). About half of sero-negatives were offered counselling on mobile
phones; completion rate: 44.6% (95% CI, 38.0–51.0). A majority of participants (78.1%) were females, aged 18–24 years
(61.4%). Nine participants were found sero-positive after confirmatory tests (prevalence 3.6% 95% CI, 1.8–6.9). Six of nine
positive self-tests were accurately interpreted; sensitivity: 66.7% (95% CI, 30.9–91.0); specificity:100% (95% CI, 98.1–100).
Interpretation: Our unsupervised self-testing strategy was feasible to operationalize in health care workers in South Africa.
Linkages were successfully operationalized with mobile phones in all sero-positives and about half of the sero-negatives
sought post-test counselling. Controlled trials and implementation research studies are needed before a scale-up is
considered.
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Introduction
A vast proportion of HIV infected individuals worldwide (6/10)
do not know their serostatus [1]. This is because HIV testing in
health care facilities are impeded by long wait times, lack of
privacy and fear of loss of confidentiality of test results, and stigma
and discrimination associated with an HIV diagnosis [2–4]. A self-
testing strategy for HIV offers a private and confidential
alternative to facility-based tests, but evidence on feasibility of
self-testing from South Africa remains limited.
Knowledge of HIV sero-status with self-tests could influence
risk-taking behaviours and impact risk reduction [5–7]. If self-tests
could successfully be offered to proactive self testers with expedited
counselling and referral to linkages, then, the strategy could
potentially increase awareness of sero-status, and improve
engagement of patients with health systems. Further, with timely
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treatment initiation, control of HIV infection and expanded access
to HIV testing is a possibility [8]. However, observational research
evidence is needed before trials are attempted.
South Africa has the world’s highest global HIV/AIDS burden
[9]. With an absolute burden of infection at 5.26 million of a total
population of 10 million and an annual incidence in 15–49 age
group of 0.85 m, it tops the world in HIV/AIDS statistic [10].
Despite a high endemicity of HIV infection, anecdotally only 50%
of South Africans self report for having tested for HIV at least once
in their lifetime [11]. This is largely due to the fact that the affected
marginalized populations (i.e., migrant workers, women, commer-
cial sex workers, men who have sex with men) who are at risk for
HIV face social and structural barriers that hamper access to
facility-based HIV testing. These barriers include fear of social
visibility, fear of lack of confidentiality regarding test results, a lack
of privacy associated with HIV testing in health care facilities, and
rampant stigma and discrimination of HIV infected populations in
these settings.
Despite availability of generic antiretroviral treatment, an early
engagement to care is not yet a reality in South Africa. There is an
urgent need to arrange for private and confidential alternatives to
facility-based testing. To address this public health need, we
developed an innovative, synergistic, HIV self-testing strategy that
can be performed with oral HIV tests, and in future, in the
comforts of one’s own home. We evaluated this strategy in a
population of health care workers (HCW) from the University of
Cape Town. HCW are at a high risk of getting infected with HIV
because of the nature of their profession, are anecdotally known to
self-test for HIV, but less likely to engage in testing due to fear of
loss of confidentiality, privacy and social visibility associated with
facility based tests [12]. In this report, we describe the results from
a pilot evaluation of this innovative strategy .
Self-testing is a process that requires a certain level of self-
motivation to purchase the test, perform the test properly,
interpret the self-test result accurately, and proactively seek
linkages to counselling, confirmatory testing or treatment (as the
case may be) by contacting a counsellor or health center, either in
person or on phone or internet [13] Realizing that self-test
conduct and interpretation were key to obtaining an accurate
result, and linkages to treatment( in self test positives) or
counselling (in self test negatives) were essential to the success of
the strategy, we developed innovations to support these aspects.
In a recent systematic review, we summarized global evidence
on the two self-testing strategies that have been evaluated
worldwide [13]: a) a supervised self-testing strategy, and b) an
unsupervised self-testing strategy [13]. In a supervised self-testing
strategy, participants perform the self-testing process by themselves
in a private kiosk set up in a clinic or outreach facility, with
assistance offered at any time by a counsellor or health care
professional, that are available on site. In contrast, in an
unsupervised self-testing strategy, the self-testers not only perform,
interpret and record the HIV self-test themselves, but also
proactively seek linkages to counselling and treatment (over the
phone, internet or face-to-face) facilitated by counsellors poten-
tially available 24/7/ [14]. While global evidence on the
supervised self-testing strategy exists, evidence on the unsupervised
self-testing strategy is non-existent especially from Southern Africa
[13].
In this report, we present results from a pilot cross sectional
study that evaluated an unsupervised self-testing strategy evaluated
in HCWs. We primarily estimated feasibility of the self-testing
strategy defined by the completion rate (i.e. completion of self-test
conduct, linkages to ART in seropositives and risk reduction
counselling in seronegatives). Our secondary objectives were to: 1)
evaluate the self-test’s accuracy, 2) document participant prefer-
ences, concerns and experience with the self-testing strategy, and,
3) evaluate HIV sero-positivity.
Methods
Two Institutional Review Boards based at McGill University
Health Centre Montreal, Canada and at the University of Cape
Town, South Africa approved the study. Written informed consent
was obtained from all participants. Research was conducted in
accordance with the principles expressed in the Declaration of
Helsinki.
Our innovative strategy consisted of two self-testing applica-
tions; internet-based and paper-based (refer Figure 1). These were
synergized with counsellors who offered post-test counselling and
arranged for expedited referrals over phones. Our applications
included: a) an oral HIV rapid point-of-care (POC) test approved
for use in South Africa (OraQuick Rapid HIV-1/2 Antibody Test,
OraSure Technologies, Inc., PA, USA); b) pre-test counselling and
information on HIV; c) Self-staging questions for HIV risk that
generated a self-rated HIV risk score of high, medium or low risk
for HIV; d) instructions to self-test (i.e., videos, pictures); e) linkages
to post-test counselling, over the phone or face-to-face (if
preferred) operationalized confidentially ; f) anonymized self-test
confidential record and interpretation on the application, and
lastly g) anonymized data collection on demographics, risk profile,
preferences and concerns with self-testing.
Between January and June 2012, we enrolled 251 HCW (e.g.
doctors, nurses, lab technicians) in a cross-sectional study at
Groote Schurr Hospital, a tertiary care centre in Cape Town,
South Africa. HCWs who spoke English, were 18 years of age or
older, of undocumented HIV sero-status at baseline (i.e. the
participant was unaware of his/her sero-status) and were able to
provide informed consent were recruited. This population was
chosen because: a) HCWs are at risk for HIV occupationally and
are anecdotally known to self-test, and, b) they may benefit from a
private HIV self-testing option that averts perceived stigma and
discrimination associated with seeking an HIV test in the work
place, and lastly, c) the population was digitally literate, and
desired to try out an unsupervised self-testing strategy. The study
was funded by Grand Challenges Canada. The oral test used in
our study, Oraquick (R) HIV1/2 (i.e., Orasure technologies, PA,
USA) is an FDA approved, CE marked test that is approved for
sale and use in South Africa.
Study flyers and pamphlets were pasted across the hospital
campus with the phone number and interested participants
contacted the research nurse. A convenient sample of HCW
who showed up and consented to the study procedures was
recruited. Participants were offered a choice of self-testing
applications over the Internet and on paper. They chose the
Internet or paper-based application according to their comfort and
preference levels.
After informed consent was sought, the research nurse led
participants to a private room equipped with a computer with
Internet access, a landline and a mobile phone, and an oral self-
test. Our internet-based self-testing application was administered
online. (Refer figure 1) At any time throughout the testing process,
an HIV counsellor was available to the self-tester. The self-testing
Figure 1. Applications. a) Internet- based b): Paper-based.
doi:10.1371/journal.pone.0079772.g001
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application walked the participants through various stages of self-
testing process similar to what they would experience in a health
care facility, with the exception that the testing process was
unsupervised and confidentially conducted with assistance sought
over the phone or face-to-face if desired. The internet application
consisted of HIV information (pre test counselling), a risk score
section where one could stage one’s own risk for HIV, a section
that described the ideal conduct of a self-test, a section on
interpretation of test lines, recording results of one’s own self test
result followed by a section on seeking linkages and responding to
questions about the application. Linkages were sought by a
confidential mobile phone call to a counsellor for post-test
counselling and for referral and treatment linkages. Mobile phones
and phone number were provided for this purpose. All the data
was confidentially collected online and de-identified.
The paper based application (refer: Figure 1) and process was
identical to the Internet application, except that instructions and
information were pictorially represented and results were docu-
mented on paper.The participants who chose the paper applica-
tion were also led by the research nurse to a private room to
perform their self-tests. Linkages were confidentially sought by
calling the phone number provided to them.
In parallel, blood was drawn on site from each participant for
confirmatory rapid and laboratory based testing and sent to the
reference laboratories linked by Study IDs for confirmatory
testing. A standard National Health Laboratory Services (NHLS,
Figure 2. Flow of participants and testing algorithm.
doi:10.1371/journal.pone.0079772.g002
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South Africa) approved HIV testing algorithm was used for
confirmatory testing (i.e., ELISA with p24 Antigen tests (Architect
HIV Ag/Ab Combo, Abbott Laboratories, Wiesbaden, Germany)
and Western Blot for positives). Additionally, study ID linked rapid
HIV tests SD Bio line HIV Rapid Test [Anti-HIV 1/2] (Standard
Diagnostics, Inc., Kyonggi-do, Korea) and DetermineTM HIV 1/2
Ag/Ab Combo (Alere, Waltham, MA, USA) were performed on
site.
Participants who tested positive with in-house rapid tests were
flagged for expedited confirmatory laboratory testing and results
were made available within 8 hours. All the participants were
encouraged to call the counsellor for post-test counselling.
Additionally, all house tested (rapid test) sero-positives, after
receipt of expedited lab confirmed sero-positives were contacted
by the counsellors to communicate and confirm their test results,
offer post-test counselling, advice for ART staging and arranged
for confidential referrals to a clinic of the participant’s choice. All
these services were operationalized using mobile phone calls and
text services.
Lab confirmed test results for participants that tested negative
with in-house rapid tests were available within the next working
day. All self test negative participants who called were offered risk
reduction counselling. Data was confidentially collected online
using our Internet application and was exported into an EXCEL
sheet linked by study ID. Data from paper-based application were
manually entered in an EXCEL file. Both the data sets were
merged and then analyzed in STATA version 10 (STATA Corp,
Texas, USA). With a hypothesized completion rate of the self-
testing process at 80%, a sample size of 251 gave us 95%
confidence interval (CI) widths of +/20.049. Data on demo-
graphics and risk factors were reported as proportions with 95%
CI.
Results
Of 270 participants that were approached for study participa-
tion, 251 (93.0%) consented, of which 126 completed the internet-
based application, and about 125 completed paper-based appli-
cation (Figure 2). Of 251 study participants, 249 (99.2%)
completed self-test interpretation and conduct successfully, giving
us a completion rate of 99.2%.
About nine positives were identified, of which six accurately
interpreted their self-test result. The other three participants’
reported their self-test result as ‘negative’ whereas, the in-house
rapid and confirmatory tests results were ‘positive’. The research
nurse called the participants after the receipt of lab confirmed
results as per IRB protocols. Their oral self-tests were performed
again. On repeating these tests, two of the three participants self
reported having seen a faint positive line on initial testing. On
repeat testing, the faint positive lines persisted and were confirmed
by the nurse to be positive. This suggests that self-testers may fail
to read/interpret a faint or weak positive line as a positive self-test.
At that time, our application did not have any information on the
interpretation of faint positive lines. We incorporated the fact that
any line (faint, strong or dark) was to be read as a positive line after
completion of the study. The sole participant who was missed by a
self-test was a false negative, who correctly interpreted his/her self-
test result as negative with the antibody test, and the test failed
him/her. This was because of a lack of p24 antigen in the test
device that is antibody based that fails to detect sero-conversion.
Information on this issue was included in the application.
In terms of linkages, through the use of mobile phones and
confidential text messaging, all nine sero-positives received post-
test counselling before ART staging and initiation, and were
offered expedited and confidential linkage to care to a clinic of
their choice. Therefore, our completion rates for linkages in nine
seropositive were: 100% (95% CI, 66.0–100). Likewise, in 242
sero-negatives, about half of sero-negatives called for counselling
on mobile phones, giving us a completion rate for linkages in sero-
negatives at 44.6% (95% CI, 38.0–51.0).
HIV prevalence (sero-positivity) in our study sample was 3.6%
[95% CI, 1.8–6.9]. With nine seropositives and 242 seronegatives,
the sensitivity of reading self-tests compared to lab confirmed test
results was 66.7% (95% CI, 30.9–91.0), and specificity was 100%
(95% CI, 98.1–100), However, our positive predictive value (PPV)
remained at 100% (95% CI, 51.7–100) and our negative
predictive value (NPV) was at 98.8% (95% CI, 96.2–99.7).
Sensitivity of self tests could certainly be improved with a call for
development of antibody and antigen combined self tests that can
quickly detect sero-conversion. One of these tests (Determine Alere
Antibody/Antigen) combo test that is recently approved was used
by us as in house rapid test.
Demographically, a majority of our participants, (78.1%; 196/
251), were females. About 61.4% (154/251) were aged 18–24
years, and (54%; 135/251) had completed high school. For further
details on demographics, refer to Table 1. Despite there being
three facility-based HIV testing sites within the hospital campus,
63.1% (157/251) of participants had not sought HIV testing
within the past six months and a further 33 (13%) participants had
never ever tested for HIV in their lifetime. About 78.5% (197/251)
of participants were sexually active and about 60% (150/251) self-
reported having had unprotected sex within the past six months.
About 8.8% (22/251) reported a history of needle-stick exposure
and about 3.2% (8/251) self-reported a history of sexually
transmitted infections. For further details on risk factors, refer to
Table 2.
Regarding self-testing experience, 91.2% (229/251) rated the
experience as ‘very good’ or ‘good’ because of the privacy it
offered, ease of use and non-invasive and painless nature of oral
testing. For counselling, face-to-face counselling was an option
Table 1. Demographic profile of study participants.
Gender Female 196 (78.1)
Male 53 (21.1)
Do not wish to answer 2 (0.8)




Education Did not complete high school 15 (6.0)
High school 135 (53.8)
College or technical school 61 (24.3)
Undergraduate degree 20 (8.0)
Graduate degree 6 (2.4)
Other 12 (4.8)
Do not wish to answer 2 (0.8)
Occupation Medical Professionals1 128 (51)
Staff2 123 (49)
1Attending physicians, residents, fellows, medical students, nurses, nursing
students, paramedics.
2Administrative staff, audiologists, cleaners, clerks, drivers, engineers, laboratory
technicians, porters, security.
doi:10.1371/journal.pone.0079772.t001
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acceptable to most participants (68.4%, 160/234), followed by
technology enabled counselling (via mobile phone, Internet or text
messages) at 40.6% (95/234) for post-test counselling, linkages and
referrals.
On cost preferences, 93.2% (234/251) were willing to buy the
oral self-test, with 57.7% (135/234) ready to pay R 1–50 (USD
0.10–6.30).
Other responses to our open-ended questions regarding
concerns and challenges have been summarized in Table 3.
Table 2. Sexual and Behavioral Risk Factors of study participants.
Have you ever been tested for HIV? Yes, in the past 6 months 93 (37.1)
Yes, .6 months ago 124 (49.4)
No, never been tested 33 (13.1)
Do not wish to answer 1 (0.4)
If never been tested, why? (Multiple answers) Not at risk of getting infected with HIV 13 (39.4)
Don’t want medical records to show my HIV status 5 (15.2)
Don’t want to know my HIV status 6 (18.2)
Don’t want to show up for HIV testing at a clinic 4 (12.1)
Other 6 (18.2)
Do not wish to answer 2 (6.1)
Are you sexually active Yes 197 (78.5)
No 26 (10.4)
Do not wish to answer 28 (11.2)





Do not wish to answer 2 (1.0)
Have you had unprotected sex in the past 6 months? Yes 150 (76.1)
No 44 (22.3)
Do not wish to answer 3 (1.5)
In the past 6 months, I have had sex with (multiple answers) HIV infected partner 3 (1.5)
Commercial sex worker 3 (1.5)
Under the influence of alcohol 18 (9.1)
Under the influence of drugs 3 (1.5)
None of the above 165 (83.8)
Do not wish to answer 7 (3.6)
In the past 6 months, have you injected drugs? Yes 7 (2.8)
No 243 (96.8)
Do not wish to answer 1 (0.4)
Ever had a needle-stick exposure from a patient suspected to be HIV positive? Yes 22 (8.8)
No 228 (90.8)
Do not wish to answer 1 (0.4)
If ‘‘yes’’, after this exposure, did you get tested? Yes 17 (77.3)
No 4 (18.2)
Do not wish to answer 1 (4.5)
Have you had a sexually transmitted infection? Yes 8 (3.2)
No 237 (94.4)
Do not wish to answer 6 (2.4)
Perceived risk of getting infected with HIV High 17 (6.8)
Medium 52 (20.7)
Low 163 (64.9)
Do not wish to answer 19 (7.6)
doi:10.1371/journal.pone.0079772.t002
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Discussion
We evaluated an unsupervised self-testing strategy using an
Internet application and its paper equivalent in a population of
HCWs, who wanted to learn about their HIV status with an oral
self-test and a novel approach. Despite their occupational risk for
HIV, and despite their residing for years in a high endemic setting,
a substantial proportion (63%) of participants reported not seeking
an HIV test in the past six months. Our confidential self-testing
strategy was well received, with 100% linkages for sero-positives
operationalized within 24 hours and post-test counselling for sero-
negatives offered to 44.6% participants. Additionally, a high
proportion of participants (91%) reported an overall positive self-
test experience. Similar findings on acceptability and preference
have been reported in various other studies that have evaluated
self-testing strategies [12,14–18]. However, the completion rate for
linkages of seropositive reported in our study is the highest
reported for an un-supervised self-testing strategy. As an example,
the completion rate for linkages is sero-positives in a US trial was
about 96% [15].
Completion rate of linkages in sero-negatives was lower
compared to sero-positives at 44.6%, but higher than the 29.2%
statistic traditionally reported from other facility-based testing
projects [19]. A high completion rate overall for both positives and
negatives, found in our pilot study, could be ascribed to offering a
confidential phone-based counselling strategy and use of an
internet and paper-based applications that de-identified study
participants. These results suggest that a majority of those
participants who are found to be self-test sero-positives will
possibly seek linkages to confirmatory testing, staging and care if
they are expedited, privately arranged, and offered in a
personalized manner with their preferred counselling option.
Results however need to be confirmed in other at risk
populations such as men who have sex with men, commercial
sex workers, and young pregnant women that have a high HIV
burden that may also desire confidential and personalized self-
testing. Linkage data for self-testing initiatives are currently
limited; therefore the study adds new important data from South
Africa.
Table 3. Participant feedback to open ended questions.
Reflections on self-testing experience
Test Administration ‘‘Test is easy and simple to use, results are easily interpreted’’
‘‘I had a good experience having to test myself and that no blood was needed or
needles involved during the test’’.
‘‘I think this is a very good self-testing programme computer wasn’t that bad but
everybody don’t have access or can use a computer.’’
Privacy I think it is good that they’ve come up with a test like this, now I can do it in the privacy
and comfort at home.’’
Factors influencing stress ‘‘ I feel that this is a great way of testing because many people fear the whole process
of being tested at the clinics’’
‘‘It feels uncomfortable to check on my results. It is better if somebody told you.’’
‘‘When I was doing the self-testing I was a bit nervous because I know that I had a high
risk of being HIV positive.’’
Views on knowing status and personal risk
HIV status ‘‘I feel confident knowing my HIV status’’
‘‘It was a challenging experience but also gives you peace of mind in a way after the
results’’
‘‘It’s a good device especially for people who are often very scared of doing their HIV
test at clinics, but for other people who would take their HIV positive status very hard it
would not be a better option, because that person can kill themselves at home if they
are alone.’’
Personal risk ‘‘It opened my eyes because I thought I was very safe but now I know I am HIGH RISK
and I don’t think the questions are too personal. They are straight forward.’’
‘‘Questions were relevant and straight to the point, they helped me to understand more
about the risks associated with HIV’’
Views on taking self-testing public
Making HIV self-testing public ‘‘It is a good idea and I think this method should also go to people that are in the
communities and also in schools and it must be available in the pharmacy.’’
‘‘Self-testing is great. But it would be better, if you sell it, to give a number to the person
that will buy - the number of the counsellor in case of what the results will be and how
will he/she handle them, before testing, or they can use a pharmacist to counsel the
buyer’’
Promotion of HIV self-testing ‘‘I found the test interesting – will refer it to my friends and colleagues’’
‘‘…I feel that more people will be willing to get tested now in the privacy of their own
home as many people are concerned about going to a healthcare practitioner or
facility’’
doi:10.1371/journal.pone.0079772.t003
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Regarding diagnostic performance, the PPV, NPV, and
specificity values of the self-test were high, but due to the low
number of true self-test positives, our sensitivity estimates were
low. Three self-test ‘negative’ participants who were contacted
later voluntarily showed up for re-testing. Upon re-testing, two of
three ‘negative self tests’ were discovered to have had faint positive
lines self interpreted as ‘negative’ thus, highlighting the possibility
of user errors in conduct and interpretation. In our study id linked
positive sero-status was confirmed with the in-house rapid test and
additionally, with laboratory confirmed test results, which were
given by the research nurse to the participant. Interpreting faint
positive lines was not included in our initial versions of self-testing
applications, and this may have impacted participants’ interpre-
tation of a line. Interestingly, faint lines were also recently reported
in the FDA document for approval of the self-test in the United
States [15]. Following that, we improved our applications to state
that any line with the self-test should be interpreted as a positive
line. Although our sensitivity estimates improved with re-testing, to
88.9% (95% CI, 50.7–99.4), this phenomenon could occur in scale
up initiatives.
Besides, expedited confirmatory and in house rapid testing also
picked up the lone self-test negative tester that was not picked up
by the oral antibody-based test because of sero-conversion. To
further analyze this finding, we know that the oral antibody-based
self-test is very sensitive at and after 90 days, therefore, the self-
testers must be encouraged to re-test themselves after 90 days,
particularly, if there is a high suspicion of a recent exposure, or a
perceived risk of having an acute infection but the self test is found
to be negative in these situations.
To conclude, the occurrence of user errors and inability of the
test to pick up early/acute infection highlights the importance of
providing clear instructions to the self-testers including limitations
of self tests. Clear instructions on paper, the internet or on
smartphone applications facilitate interpretation and enhance
accurate performance of self-tests. Instructions will help avoid
many errors in future. It is important to educate the public about
the limitation of antibody-based test [20]. Therefore, to ensure the
success of self-testing, messages regarding an accurate interpreta-
tion of positive lines and the limitation of the ability of the test to
detect new infections within 90 days must at all times be
emphasized.
At the FDA deliberations over approval of self-tests, arguments
of access to HIV testing, won over arguments of sensitivity.
Additionally, we have recently reviewed global evidence on the
accuracy of these oral rapid antibody tests in an implementation
research context. We found them to be 98.03% sensitive (95% CI,
95.85–99.08) and 99.74% (95% CI, 99.47–99.88) specific in
research settings [20]. We converted our tested Internet applica-
tion to an Android smartphone application (refer to Figure 3). This
android application is available in English and could be
downloaded to the Android phones. The smartphone application
assists in understanding the process of self-testing and facilitates
confidential linkages. This award winning application is copy-
righted (no 4231105598), and owned by McGill University. Lastly,
although successful use of internet-based strategies have been
reported for sexually transmitted infections, and for HIV in global
settings. But, to the best of our knowledge, no pilot study has
synergized Internet, public health counsellors and mobile phones
with an oral HIV test, and offered an integrated unsupervised self-
testing strategy [21–25]. Our strategy offered complete confiden-
tiality and anonymity in testing – a fact greatly appreciated by all
the study participants.
Limitations
This pilot study was conducted in a convenient sample of
HCWs who consented to the evaluation of an unsupervised oral
fluid based self-testing strategy. Selection and volunteer bias are
likely. Misclassification of self-test results could lead to a potential
for information bias.
Although the pilot study was successful, it needs to be repeated
in other at risk populations to generate stronger evidence for
feasibility of this strategy. These studies are being planned in scale
up of this project. The study results are generalizable to HCWs
who would show up for participation if a supervised self-testing
strategy were offered again at any of the hospitals. Future scale up
studies that evaluate innovative interventions in at risk populations
such as men who have sex with men, pregnant women,
commercial sex workers and adolescents will serve to generate
stronger evidence of generalizability to at risk populations.
Although in a high endemic setting, one could argue that routine
HIV testing should be conducted in all populations and more so in
populations that are at risk in hospitals and other health care
settings.
Conclusion
To conclude, self-testing offers a discreet, viable, private, option
to test provided confidentiality is maintained and expedited
Figure 3. A HIV self-testing Smartphone Application (McGill
University copyright no: 1105598).
doi:10.1371/journal.pone.0079772.g003
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linkages within a reasonable time window are made available. Our
study demonstrates that linkages can be operationalized confiden-
tially, and successfully with phones. Although our innovative, un-
supervised self-testing strategy was well received by HCWs in
South Africa, larger real life implementation research studies and
controlled trials on self-testing are urgently needed to generate
stronger evidence for scale up. Following up on a recent call from
the WHO for pilot feasibility studies, this study has generated data
on feasibility. Our findings have implications for future planning of
scale up studies for Southern African region and similar regions
and settings in Asia.
Acknowledgments
We acknowledge our study participants and staff of the University of Cape
Town.
Author Contributions
Conceived and designed the experiments: NPP KD SS TB CV AB SP LJ
LA RDH NE. Performed the experiments: NPP TB LA CV SS SP AB
RDH NE LJ KD. Analyzed the data: LJ NPP SS TB. Contributed
reagents/materials/analysis tools: NPP TB LA CV SS SP AB RDH NE LJ
KD. Wrote the paper: NPP TB LA CV SS SP AB RDH NE LJ KD.
References
1. WHO, UNICEF, UNAIDS (2010) JUNPoHA Towards universal access: scaling
up priority HIV/AIDS interventions in the health sector: progress report 2010.
Geneva, Switzerland. Accessed 2013 Oct 1.
2. Meiberg AE, Bos AER, Onya HE, Schaalma HP (2008) Fear Of Stigmatization
As Barrier To Voluntary HIV Counselling And Testing In South Africa. East
Afr J Public Health 5: 49–54.
3. Kalichman SC, Simbayi LC (2003) HIV testing attitudes, AIDS stigma, and
voluntary HIV counselling and testing in a black township in Cape Town, South
Africa. Sex Transm Infect 79: 442–447.
4. Walensky RP, Paltiel AD (2006) Rapid HIV Testing at Home: Does It Solve a
Problem or Create One? Ann Intern Med 145: 459–462.
5. Schlumberger MG, Desenclos J, Papaevangelou G, Richardson SC, Ancelle-
Park R (1999) Knowledge of HIV serostatus and preventive behaviour among
European injecting drug users: Second study. Eur J Epidemiol 15: 207–215.
6. MacNeil JM, Mberesero F, Kilonzo G (1999) Is care and support associated with
preventive behaviour among people with HIV? AIDS Care 11: 537–546.
7. Marks G, Crepaz N, Senterfitt JW, Janssen RS (2005) Meta-Analysis of High-
Risk Sexual Behavior in Persons Aware and Unaware They are Infected With
HIV in the United States: Implications for HIV Prevention Programs. AIDS 39:
446–453.
8. Mills EJ, Bakanda C, Birungi J, Yaya S, Ford N, et al. (2012) The prognostic
value of baseline CD4(+) cell count beyond 6 months of antiretroviral therapy in
HIV-positive patients in a resource-limited setting. AIDS 26: 1425–1429.
9. UNAIDS, WHO (2011) Global HIV/AIDS Response: Epidemic update and
health sector progess towards Universal Access - Progress report 2011. Available:
http://www.unaids.org/en/media/unaids/contentassets/documents/
unaidspublication/2011/20111130_ua_report_en.pdf. Accessed 2013 Oct 11.
10. Africa SS (2012) Mid-year population estimates, 2011. Pretoria. Available:
http://www.statssa.gov.za/publications/P0302/P03022013.pdf. Accessed 2013
Sept 30.
11. Richter M, Venter WDF, Gray A (2010) Home self-testing for HIV: AIDS
exceptionalism gone wrong. S Afr Med J 100.
12. Kalibala S, Tun W, Muraah W, Cherutich P, Oweya E, et al. (2011) ‘Knowing
myself first’: feasibility of self-testing among health workers in Kenya. Nairobi:
Population Council.
13. Pai NP, Sharma J, Shivkumar S, Pillay S, Vadnais C, et al. (2013) Supervised
and unsupervised self-testing for HIV in high- and low-risk populations: a
systematic review. PLoS Med 10: e1001414.
14. Pai NP, Bhargava M, Sharma J, Balram B, Joseph L, et al. (2012) Will HIV self
testing be accepted by low to medium risk educated populations? A pilot cross
sectional study in students of McGill University, Montreal. Canadian
Association for HIV Research Conference. Montreal, Quebec.
15. Technologies O (2012) Final Advisory Committee Briefing Materials: Available
for Public Release, in OraQuickH In-Home HIV Test.
16. Carballo-Dieguez A, Frasca T, Balan I, Ibitoye M, Dolezal C (2012) Use of a
rapid HIV home test prevents HIV exposure in a high risk sample of men who
have sex with men. AIDS Behav 16: 1753–1760.
17. Gaydos CA, Hsieh YH, Harvey L, Burah A, Won H, et al. (2011) Will patients
‘‘opt in’’ to perform their own rapid HIV test in the emergency department?
Ann Emerg Med 58: S74–78.
18. de la Fuente L, Rosales-Statkus ME, Hoyos J, Pulido J, Santos S, et al. (2012)
Are participants in a street-based HIV testing program able to perform their
own rapid test and interpret the results? PLoS One 7: e46555.
19. Anderson JE, Carey JW, Taveras S (2000) HIV testing among the general US
population and persons at increased risk: information from national surveys,
1987–1996. Am J Public Health 90: 1089–1095.
20. Pai NP, Balram B, Shivkumar S, Martinez-Cajas J, Claessens C, et al. (2012)
Head-to-head comparison of accuracy of a rapid point-of-care HIV test with
oral versus whole-blood specimens: a systematic review and meta-analysis.
Lancet Infect Dis 12: 373–380.
21. van der Helm J, Zuure F, Fennema H, Davidovich U, Prins M (2012)
Announcing a new method of HIV testing: the planning of robust home testing
for HIV combined with internet counseling. 19th International AIDS
Conference. Washington D.C.
22. Spielberg F, Quraishy ZB, Crean K, Wilson D, Kumar P, et al. (2007)
Computer counseling and self-testing for HIV prevention in Southern India.
Seattle, Washington.
23. Hottes TS, Farrell J, Bondyra M, Haag D, Shoveller J, et al. (2012) Internet-
based HIV and sexually transmitted infection testing in British Columbia,
Canada: opinions and expectations of prospective clients. J Med Internet Res 14:
e41.
24. Gaydos CA, Dwyer K, Barnes M, Rizzo-Price PA, Wood BJ, et al. (2006)
Internet-based screening for Chlamydia trachomatis to reach non-clinic
populations with mailed self-administered vaginal swabs. Sex Transm Dis 33:
451–457.
25. Masek BJ, Arora N, Quinn N, Aumakhan B, Holden J, et al. (2009) Performance
of three nucleic acid amplification tests for detection of Chlamydia trachomatis
and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an
Internet-based screening program. J Clin Microbiol 47: 1663–1667.
An Unsupervised HIV Self-Testing Strategy
PLOS ONE | www.plosone.org 9 November 2013 | Volume 8 | Issue 11 | e79772
